Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery
Zhou Tian, Zhu Xinyi, Ye Zhizhong, Wang Yong-Fei, Yao Chao, Xu Ning, Zhou Mi, Ma Jianyang, Qin Yuting, Shen Yiwei, Tang Yuanjia, Yin Zhihua, Xu Hong, Zhang Yutong, Zang Xiaoli, Ding Huihua, Yang Wanl
Journal:Nature Communications
IF:17.69
DOI:10.1038/s41467-022-29514-y
PMID:35388006
Published:2022-04-06
research field:分子生物学电化学生物技术癌症诊断
Abstract
Despite strong evidence that human genetic variants affect the expression of many key transcription factors involved in autoimmune diseases, establishing biological links between non-coding risk variants and the gene targets they regulate remains a considerable challenge. Here, we combine genetic, epigenomic, and CRISPR activation approaches to screen for functional variants that regulate IRF8 expression. We demonstrate that the locus containing rs2280381 is a cell-type-specific enhancer for IRF8 that spatially interacts with the IRF8 promoter. Further, rs2280381 mediates IRF8 expression through enhancer RNA AC092723.1, which recruits TET1 to the IRF8 promoter regulating IRF8 expression by affecting methylation levels. The alleles of rs2280381 modulate PU.1 binding and chromatin state to regulate AC092723.1 and IRF8 expression differentially. Our work illustrates an integrative strategy to define functional genetic variants that regulate the expression of critical genes in autoimmune diseases and decipher the mechanisms underlying the dysregulation of IRF8 expression mediated by lupus risk variants.
本文使用的Yeasen产品


